Cite
HARVARD Citation
Gottenberg, J. et al. (2022). Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases). RMD open. 8 (2), p. . [Online].